Identification of proteomic signatures associated with lung cancer and COPD.
about
Proteomic-Based Approaches for the Study of Cytokines in Lung CancerFree radicals: properties, sources, targets, and their implication in various diseasesData from a comparative proteomic analysis of tumor-derived lung-cancer CD105(+) endothelial cells.Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer.Application of proteomics and peptidomics to COPD.The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinomaValidation of a multiprotein plasma classifier to identify benign lung nodulesDifferentially expressed and activated proteins associated with non small cell lung cancer tissuesBlood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumMining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.Role of WWOX and NF-κB in lung cancer progressionAbnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer.Alterations in the proteome of the respiratory tract in response to single and multiple exposures to naphthalene.Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.Glutathione S-transferase pi modulates NF-κB activation and pro-inflammatory responses in lung epithelial cells.Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro.SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.Knockdown of Tubulin Polymerization Promoting Protein Family Member 3 Suppresses Proliferation and Induces Apoptosis in Non-Small-Cell Lung Cancer.Fetuin-B (FETUB): a Plasma Biomarker Candidate Related to the Severity of Lung Function in COPDSpecific autoantigens identified by sera obtained from mice that are immunized with testicular germ cells alone.Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes.Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung CancerBiomarker discovery in asthma and COPD by proteomic approaches.Asthma and COPD proteomics: current approaches and future directions.Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.A Quantitative Proteomics Approach to Clinical Research with Non-Traditional Samples.miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin.Increase in the expression of leukocyte elastase inhibitor during wound healing in corneal endothelial cells.Discovery and microassay of a nitrite-dependent carbonic anhydrase activity by stable-isotope dilution gas chromatography-mass spectrometry.Overexpression of calcyphosine is associated with poor prognosis in esophageal squamous cell carcinoma.Recent insights into human bronchial proteomics - how are we progressing and what is next?Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma.Targeting FBPase is an emerging novel approach for cancer therapy.Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.Whole exome sequencing of rare aggressive breast cancer histologies.Down Expression of FBP1 Is a Negative Prognostic Factor for Non-Small-Cell Lung Cancer.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
P2860
Q26738539-7603BFBE-2619-4B41-AE20-FBD430384FC7Q27000071-9134E9D3-2E21-4E89-89EA-E392DE6B74C6Q31077865-46A77CC5-C3A7-4EEB-A05F-CD02668DE431Q33610918-027A1C4C-F380-44B2-BF18-22255BD50EA9Q33634488-06620F36-14C7-4D6E-8E6F-34ECE90B60D7Q35200467-A6622EE9-2E0A-4A4C-99CA-703D2A28246FQ35241794-FF7C92DC-76C8-48CA-9A46-6937464F9962Q35805319-E459C235-D9C4-40A1-9050-F721D7411090Q35957217-733A22B8-20CB-431B-BA27-0FB70822BB9DQ36285296-572DCFAC-A9A8-47C5-9571-D269296F99A4Q36292690-FB33A42B-C069-4F7E-8326-3CD7CA6057DCQ36380685-F719D848-0DF6-4E0A-898F-DB7E9B4B6BCEQ36468642-FE6DA3D5-F5F1-45C5-B7A0-2083E4F2DD98Q36543873-F9408F00-5D4F-4902-86E9-AB93E865F368Q36635127-68CB1DA6-BFF2-4189-B4ED-011692C8328BQ36710603-D9FFDEC2-B995-4340-9607-D875978E7646Q36787561-7618FFFE-CC57-4DC1-9782-C271FA228111Q36817330-FAB6549F-516D-4017-9657-406614CBF03AQ36962895-04389B2E-30D4-4A5C-9C4B-9D65C9560F89Q37067972-C89A6691-BFFC-4E38-9D34-F9F371C945B1Q37117439-912A1D50-11B6-40DD-868B-3A6A194FB5DFQ37345382-D288240A-7C95-48A8-ACF4-557226E2D03BQ37454408-A403EA80-B53C-48CB-820C-A021E1834B8DQ37627629-BD14C1E4-F063-465D-8D43-EEDA96B41798Q38245908-8D5A1B27-56CB-42CC-A028-845857017E3AQ38287694-97525AF8-7CFB-4F1D-A758-405B9DA19A05Q38856893-09C9E2EC-29C8-4949-8771-30B1A917DB81Q41227539-ABAD753B-4796-4D4B-92A4-441DB27EC7D1Q41832554-EE62A463-DE9D-43D9-90CC-F706C5B96F2FQ42256563-15F3E9F6-F9B3-45F1-BDC0-DB43F5838604Q42478466-52E7B2F1-6386-4EC8-88A0-AE8FD48D4F69Q46675324-E98075F1-1434-4A75-8101-362E8F9F5D81Q47134688-8B156FF7-3AA4-4A29-A0AB-C6410B54B1BBQ47271963-55C8148B-E523-4C14-B236-DCE591D9A769Q51106997-CB24F591-3551-407C-857F-A978C8484E85Q52647812-09FA9A9F-3BC2-43C3-BFE1-21BF1AAC33FAQ52936872-8C17B52E-0CE5-45EB-B4CA-27F424091DE1Q53166630-3C0524A3-38FF-4BA7-ACE5-B54E85D64EF4Q53556638-62915288-6A78-49EB-ABDA-64B10838FE79Q54962725-0884319F-8333-411F-9C2F-89C562498AB2
P2860
Identification of proteomic signatures associated with lung cancer and COPD.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of proteomic signatures associated with lung cancer and COPD.
@ast
Identification of proteomic signatures associated with lung cancer and COPD.
@en
Identification of proteomic signatures associated with lung cancer and COPD.
@nl
type
label
Identification of proteomic signatures associated with lung cancer and COPD.
@ast
Identification of proteomic signatures associated with lung cancer and COPD.
@en
Identification of proteomic signatures associated with lung cancer and COPD.
@nl
prefLabel
Identification of proteomic signatures associated with lung cancer and COPD.
@ast
Identification of proteomic signatures associated with lung cancer and COPD.
@en
Identification of proteomic signatures associated with lung cancer and COPD.
@nl
P2093
P50
P1476
Identification of proteomic signatures associated with lung cancer and COPD
@en
P2093
J Martín-Juan
L Paz-Ares
M González De la Peña
R Meléndez
P304
P356
10.1016/J.JPROT.2013.04.037
P577
2013-05-09T00:00:00Z